Phase II Safety and Efficacy Study of CG0070 Oncolytic Vector Regimen in Patients With High Grade Non-Muscle Invasive Bladder Carcinoma Disease (NMIBC) Who Have Failed BCG and Refused Cystectomy
NCT02143804 · WITHDRAWN · Phase 2
We track 1 ClinicalTrials.gov studies led by Cg Oncology Inc. The portfolio skews toward Phase 2 (1 trials).
1 clinical trials sponsored by Cg Oncology Inc.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 100% |
Cg Oncology Inc currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 2.
Cg Oncology Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.
Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.